サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ヘルスケア分析試験サービス市場規模、シェア＆動向分析レポート：タイプ別（医療機器、医薬品）、地域別（APAC、北米、欧州、MEA）、セグメント別予測、2022年～2030年
市場調査レポート
商品コード
1122100

ヘルスケア分析試験サービス市場規模、シェア＆動向分析レポート：タイプ別（医療機器、医薬品）、地域別（APAC、北米、欧州、MEA）、セグメント別予測、2022年～2030年

Healthcare Analytical Testing Services Market Size, Share & Trends Analysis Report By Type (Medical Device, Pharmaceutical), By Region (APAC, North America, Europe, MEA), And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 98 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ヘルスケア分析試験サービス市場規模、シェア＆動向分析レポート：タイプ別（医療機器、医薬品）、地域別（APAC、北米、欧州、MEA）、セグメント別予測、2022年～2030年
出版日: 2022年08月02日
発行: Grand View Research
ページ情報: 英文 98 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケア分析試験サービス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のヘルスケア分析試験サービス市場規模は、2030年までに251億米ドルに達し、予測期間中に8.3%のCAGRを記録すると予測されています。医療用分析試験サービスのアウトソーシングの増加、バイオシミラーの需要拡大、臨床試験件数の増加などが、業界の成長を促す主な要因となっています。また、COVID-19のパンデミックも業界の成長に寄与しています。バイオシミラーとは、FDAの承認を受けた医薬品で、生物学的製剤の承認された特徴を多く有しています。生物学的製剤と比較した場合、より安価で効果的な治療の選択肢となり、今後数年間で需要が大幅に増加すると予測されています。

Sandoz International GmbHの記事では、バイオシミラー医薬品の開発において分析試験が重要なステップであることが強調されており、このようなサービスへの需要が増加することが示されています。COVID-19の世界の流行は、そのようなサービスの提供者に高い成長機会を提供すると予想されます。世界中の製薬会社がワクチン治療薬やCOVID-19の治療薬の開発のための臨床試験を開始したため、分析試験の需要が増加しています。また、コロナウイルス対策として、医療機器や医薬品を顧客に配布する前に厳格な試験を受ける必要があるため、世界な要件を満たす必要性が高まっており、業界の生産量を押し上げています。このことは、このようなサービスの需要を増大させると予想されます。

ヘルスケア分析試験サービス市場レポートハイライト

医療機器と医薬品市場は厳しい規制があるため、市場成長を促進する分析試験サービスを採用しています。

医薬品分析試験サービス市場は、2021年に58.5%の最大市場シェアを占めた

北米は、米国最大の臨床試験市場の存在により、2021年に53.7%の最大売上高シェアで世界市場を独占。

アジア太平洋地域は、予測期間中に最も速いCAGR 9.5%で成長すると予測されています。

この成長は、同地域のさまざまな国々で新しい施設が開発・拡張されたことに起因しています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • タイプ
    • リージョンスコープ
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査内容
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析（モデル1）
      • アプローチ1：コモディティフローアプローチ
    • ボリューム価格分析（モデル2）
      • アプローチ2：出来高分析
  • 二次情報一覧
  • 一次情報のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 ヘルスケア分析試験サービス市場の変数、動向、範囲

  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制分析
    • 業界の課題
  • ヘルスケア分析試験サービス市場分析ツール
    • 業界分析- ポーターズ
      • サプライヤーの力
      • 買い手の交渉力
      • 代替の脅威
      • 新規参入者の脅威
      • 競争企業間の敵対関係
    • PESTEL分析
      • 政治情勢
      • 技術情勢
      • 経済情勢
    • 主要取引と戦略的提携分析
    • COVID-影響分析

第4章 ヘルスケア分析試験サービス市場：タイプの推定・動向分析

  • セグメントダッシュボード
  • ヘルスケア分析試験サービスの市場シェア、2021年および2030年
  • 2018年から2030年までの以下の市場規模と予測、トレンド分析
    • 医療機器分析試験サービス
      • 抽出可能および浸出可能
      • 材料特性評価
      • 物理試験
      • バイオバーデン試験
      • 無菌試験
      • その他のテスト
    • 医薬品分析試験サービス
      • 生物分析試験
      • メソッドの開発と検証
      • 安定性試験
      • その他の試験サービス

第5章 ヘルスケア分析試験サービス市場：地域推定・動向分析

  • 地域市場ダッシュボード
  • 地域市場シェア分析、2021年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • インド
    • 日本
    • 中国
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • チリ
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第6章 競合情勢

  • 主要な市場参加者別最近の動向と影響分析
    • Pharmaceutical Product Development
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • ICON plc
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • LabCorp
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Charles River Laboratories International Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Syneos Health
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • SGS SA
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Toxikon, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Intertek Group
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Pace Analytical Services, LLC
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Eurofins Scientific
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 5 Global Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 7 North America Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 9 North America Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 15 Canada Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 18 Europe Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 U.K. Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 22 U.K. Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 U.K. Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 25 Germany Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 France Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 28 France Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 29 France Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Italy Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 31 Italy Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Spain Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 34 Spain Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 India Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 41 India Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 India Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Japan Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 44 Japan Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 Japan Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 China Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 47 China Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 China Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 49 Australia Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 50 Australia Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Australia Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 South Korea Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 53 South Korea Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 54 South Korea Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Latin America Healthcare Analytical Testing Services Market, by Region, 2018 - 2030 (USD Million)
  • Table 56 Latin America Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 57 Latin America Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 Latin America Pharmaceutical Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Brazil Healthcare Analytical Testing Services Market, by type, 2018 - 2030 (USD Million)
  • Table 60 Brazil Medical Device Analytical Testing Services Market, by Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Healthcare analytical testing services market: Market snapshot
  • Fig. 8 Healthcare analytical testing services market: Market segmentation
  • Fig. 9 Healthcare analytical testing services market Strategy framework
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Healthcare analytical testing services market driver impact
  • Fig. 13 Healthcare analytical testing services market restraint impact
  • Fig. 14 Healthcare analytical testing services market porter's five forces analysis
  • Fig. 15 Healthcare analytical testing services market PESTEL analysis
  • Fig. 16 Healthcare analytical testing services market segment dashboard
  • Fig. 17 Healthcare analytical testing services market: Type movement Analysis
  • Fig. 18 Medical device analytical testing services estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Extractable and leachable estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Material characterization estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Physical testing estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Bioburden testing estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Sterility testing estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Other tests estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceutical analytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Bioanalytical testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Method development and validation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Stability testing estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Other testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global healthcare analytical testing services market: Regional movement analysis
  • Fig. 31 Global healthcare analytical testing services market: Regional outlook and key takeaways
  • Fig. 32 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Colombia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Chile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-297-3

Healthcare Analytical Testing Services Market Growth & Trends:

The global healthcare analytical testing services market size is expected to reach USD 25.1 billion by 2030, registering a CAGR of 8.3% over the forecast period, according to a new report by Grand View Research, Inc. The increasing outsourcing of healthcare analytical testing services, growing demand for biosimilars, and rising number of clinical trials are some of the key factors that are driving the industry's growth. In addition, the COVID-19 pandemic contributed to the growth of the industry. Biosimilars are medications that have received FDA approval and share many biologic medicines' approved features. When compared to biologics, they are a more affordable and effective treatment alternative, and it is projected that this will significantly increase demand in the coming years.

Analytical testing is highlighted as a crucial step in the development of biosimilars in a Sandoz International GmbH article, which increases demand for such services. The global COVID-19 pandemic is expected to offer high growth opportunities to the providers of such services. As pharmaceutical companies across the world have started clinical trials for the development of vaccines therapeutics, and medications for the treatment of COVID-19, the demand for analytical testing has increased. Also, to combat the coronavirus, the growing need to meet the global requirements of medical devices and pharmaceutical products, which must undergo rigorous testing before being distributed to customers, has boosted the production in the industry. This, in turn, is expected to augment the demand for such services.

Healthcare Analytical Testing Services Market Report Highlights:

  • The medical device and pharmaceutical market has strict regulations so they are adopting analytical testing services that are driving the market growth
  • The Pharmaceutical Analytical Testing Services market held the largest market share of 58.5% in 2021
  • North America dominated the global market with the largest revenue share of 53.7% in 2021 owing to the presence of the largest clinical trials market in the U.S.
  • The Asia Pacific region is anticipated to grow at the fastest CAGR of 9.5% during the forecast period
  • This growth can be credited to the development and expansion of new facilities in different countries present in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Region scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key service and type scopes to conclude on the market size.

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Analytical Testing Services Market Variables, Trends & Scope

  • 3.1. Penetration & Growth Prospect Mapping
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Industry challenges
  • 3.3. Healthcare Analytical Testing Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Major Deals & Strategic Alliances Analysis
    • 3.3.4. COVID- Impact Analysis

Chapter 4. Healthcare Analytical Testing Services Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Healthcare Analytical Testing Services Market Share, 2021 & 2030
  • 4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.3.1. Medical Device Analytical Testing Services
      • 4.3.1.1. Extractable & Leachable
      • 4.3.1.2. Material Characterization
      • 4.3.1.3. Physical Testing
      • 4.3.1.4. Bioburden Testing
      • 4.3.1.5. Sterility Testing
      • 4.3.1.6. Other Tests
    • 4.3.2. Pharmaceutical Analytical Testing Services
      • 4.3.2.1. Bioanalytical Testing
      • 4.3.2.2. Method Development & Validation
      • 4.3.2.3. Stability Testing
      • 4.3.2.4. Other Testing Services

Chapter 5. Healthcare Analytical Testing Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2021 & 2030
  • 5.3. North America
    • 5.3.1. Market estimates and forecast by country, 2018 - 2030 (USD Million)
    • 5.3.2. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.3.3. U.S.
      • 5.3.3.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.3.4. Canada
      • 5.3.4.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. Market estimates and forecast by country, 2018 - 2030 (USD Million)
    • 5.4.2. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.4.3. U.K.
      • 5.4.3.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.4.4. Germany
      • 5.4.4.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.4.5. France
      • 5.4.5.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.4.6. Italy
      • 5.4.6.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.4.7. Spain
      • 5.4.7.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Market estimates and forecast by country, 2018 - 2030 (USD Million)
    • 5.5.2. India
      • 5.5.2.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.5.3. Japan
      • 5.5.3.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.5.4. China
      • 5.5.4.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Market estimates and forecast by country, 2018 - 2030 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.6.5. Colombia
      • 5.6.5.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.6.6. Chile
      • 5.6.6.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. Market estimates and forecast by country, 2018 - 2030 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.7.3. Saudi Arabia
      • 5.7.3.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. Market estimates and forecast by type, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 6.1.1. Pharmaceutical Product Development
      • 6.1.1.1. Company overview
      • 6.1.1.2. Financial performance
      • 6.1.1.3. Product benchmarking
      • 6.1.1.4. Strategic initiatives
    • 6.1.2. ICON plc
      • 6.1.2.1. Company overview
      • 6.1.2.2. Financial performance
      • 6.1.2.3. Product benchmarking
      • 6.1.2.4. Strategic initiatives
    • 6.1.3. LabCorp
      • 6.1.3.1. Company overview
      • 6.1.3.2. Financial performance
      • 6.1.3.3. Product benchmarking
      • 6.1.3.4. Strategic initiatives
    • 6.1.4. Charles River Laboratories International Inc.
      • 6.1.4.1. Company overview
      • 6.1.4.2. Financial performance
      • 6.1.4.3. Product benchmarking
      • 6.1.4.4. Strategic initiatives
    • 6.1.5. Syneos Health
      • 6.1.5.1. Company overview
      • 6.1.5.2. Financial performance
      • 6.1.5.3. Product benchmarking
      • 6.1.5.4. Strategic initiatives
    • 6.1.6. SGS SA
      • 6.1.6.1. Company overview
      • 6.1.6.2. Financial performance
      • 6.1.6.3. Product benchmarking
      • 6.1.6.4. Strategic initiatives
    • 6.1.7. Toxikon, Inc.
      • 6.1.7.1. Company overview
      • 6.1.7.2. Financial performance
      • 6.1.7.3. Product benchmarking
      • 6.1.7.4. Strategic initiatives
    • 6.1.8. Intertek Group
      • 6.1.8.1. Company overview
      • 6.1.8.2. Financial performance
      • 6.1.8.3. Product benchmarking
      • 6.1.8.4. Strategic initiatives
    • 6.1.9. Pace Analytical Services, LLC
      • 6.1.9.1. Company overview
      • 6.1.9.2. Financial performance
      • 6.1.9.3. Product benchmarking
      • 6.1.9.4. Strategic initiatives
    • 6.1.10. Eurofins Scientific
      • 6.1.10.1. Company overview
      • 6.1.10.2. Financial performance
      • 6.1.10.3. Product benchmarking